Bio-Path Holdings, Inc.
BPTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133818
No open-market purchases or sales by Bio-Path Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Bio-Path Holdings, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 14 | 22 | +8 |
| Shares | 59.0K | 319.1K | +260.0K (+440.3%) |
| Value | $53.5K | $370.1K | +$316.6K (+591.6%) |
New holders (10)
Institutions that held Bio-Path Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 237,561 | $275.6K | 0.01% |
| Apollon Wealth Management, LLC | 14,880 | $17.3K | 0.00% |
| Two Sigma Securities, LLC | 12,237 | $14.2K | 0.00% |
| National Bank of Canada | 10,000 | $11.6K | 0.00% |
| Cetera Investment Advisers | 10,000 | $11.6K | 0.00% |
| JPMorgan Chase & Co | 217 | $252 | 0.00% |
| SBI Securities Co., Ltd. | 151 | $175 | 0.00% |
| Tradewinds Capital Management, LLC | 50 | $58 | 0.00% |
| Synergy Investment Management, LLC | 5 | $6 | 0.00% |
| Wells Fargo & Company | 1 | $1 | 0.00% |
Sold out (2)
Institutions that held Bio-Path Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Virtu Financial LLC | 12,325 | $11.0K |
| Citadel Advisors LLC | 10,917 | $9.93K |